Developmental Trajectory of Body Weight in Youths at Risk for Major Mood Disorders.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 10 2023
Historique:
medline: 31 10 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: epublish

Résumé

Mood disorders are associated with increased body weight, especially in females, but it remains unknown when the weight increase starts. To examine sex-specific weight trajectories associated with familial mood disorder risk and determine the age at which youth at familial risk for mood disorders begin to diverge in weight from controls. This community-based, single-center, acceleration cohort study of youth at familial risk for mood disorders and controls with yearly follow-ups (mean [SD], 5 [2.1] years) from January 1, 2014, to December 31, 2022, assessed 394 unaffected female and male offspring (aged 3 to 20 years) of parents with or without a mood disorder. Parents with mood (depressive or bipolar) disorders were recruited through adult mental health services. Parents of control participants were matched on age and socioeconomic factors and recruited through acquaintance referrals or schools. The youth in the familial mood risk group had at least 1 parent with a major mood disorder, whereas control youth did not have a parent with a mood disorder. Body mass indexes (BMIs) were calculated as weight in kilograms divided by height in meters squared from measured weight and height at annual assessments and then converted to age- and sex-adjusted z scores (zBMIs). Repeated-measure regressions examined the association between zBMI and age in youth at familial risk of mood disorders and controls while accounting for sex. Sensitivity analyses accounted for socioeconomic status, prematurity, and birth weight. Of 394 participants (mean [SD] age, 11.5 [3.6] years; 203 [51.5%] female), youths at familial risk for mood disorders showed overall no difference in body weight (β = 0.12; 95% CI, 0.01-0.24) from controls. A sex-specific difference was detected, with females at familial risk showing a rapid peripubertal increase in body weight, leading to significantly increased zBMIs at 12 years and older compared with controls (β = 0.57; 95% CI, 0.31-0.82) independent of socioeconomic status, prematurity, or birth weight. Males did not differ from controls at any age. In this cohort study, females with a family history of mood disorders were prone to weight gain starting around puberty and predating mood disorder onset. Early interventions aiming to prevent adverse mental and physical outcomes in this vulnerable group need to start in childhood.

Identifiants

pubmed: 37856119
pii: 2810871
doi: 10.1001/jamanetworkopen.2023.38540
pmc: PMC10587790
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2338540

Subventions

Organisme : CIHR
ID : 124976
Pays : Canada
Organisme : CIHR
ID : 142738
Pays : Canada
Organisme : CIHR
ID : 148394
Pays : Canada
Organisme : CIHR
ID : 169025
Pays : Canada
Organisme : CIHR
ID : 172679
Pays : Canada
Organisme : CIHR
ID : 173592
Pays : Canada
Organisme : CIHR
ID : 178851
Pays : Canada
Organisme : CIHR
ID : 178222
Pays : Canada

Références

Int J Obes (Lond). 2014 Jul;38(7):906-11
pubmed: 24480863
Child Psychiatry Hum Dev. 2009 Dec;40(4):517-26
pubmed: 19404733
CMAJ Open. 2014 Jul 22;2(3):E145-52
pubmed: 25295234
Front Psychiatry. 2020 Jun 11;11:500
pubmed: 32595530
Lancet. 2022 Mar 5;399(10328):957-1022
pubmed: 35180424
Early Interv Psychiatry. 2022 Sep;16(9):1011-1019
pubmed: 34808702
Psychol Med. 2005 Mar;35(3):353-65
pubmed: 15841871
Hum Reprod Update. 2001 May-Jun;7(3):287-91
pubmed: 11392375
J Health Psychol. 2008 Nov;13(8):1190-7
pubmed: 18987092
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
J Clin Psychiatry. 2008 Dec;69(12):1953-9
pubmed: 19026266
Acta Neuropsychiatr. 2010 Dec;22(6):284-91
pubmed: 25385215
Am J Psychiatry. 2018 May 1;175(5):411-426
pubmed: 29361850
J Health Dispar Res Pract. 2016 Fall;9(3):115-126
pubmed: 28533944
Int J Eat Disord. 2021 Oct;54(10):1730-1765
pubmed: 34245459
Eur Psychiatry. 2019 Aug;60:20-27
pubmed: 31100609
Am J Psychiatry. 1979 Jan;136(1):52-6
pubmed: 758828
Curr Obes Rep. 2021 Dec;10(4):458-466
pubmed: 34599745
Schizophr Bull. 2014 Jan;40(1):28-38
pubmed: 23960245
Psychosom Med. 2017 Jun;79(5):514-523
pubmed: 28178032
Ann Epidemiol. 2019 Nov;39:1-7.e1
pubmed: 31679894
Biol Psychiatry. 2005 Aug 1;58(3):175-89
pubmed: 16084838
Br J Psychiatry. 2004 Jan;184:28-33
pubmed: 14702224
Can J Psychiatry. 2006 Apr;51(5):274-80
pubmed: 16986816
Dialogues Clin Neurosci. 2009;11(1):7-20
pubmed: 19432384
Lancet Psychiatry. 2015 May;2(5):452-464
pubmed: 26360288
PLoS One. 2017 May 11;12(5):e0177175
pubmed: 28493988
Neurosci Biobehav Rev. 2015 May;52:89-104
pubmed: 25579847
BMJ. 2013 May 21;346:f2539
pubmed: 23694688
Pediatrics. 2002 Sep;110(3):497-504
pubmed: 12205250
Bipolar Disord. 2012 Sep;14(6):641-53
pubmed: 22938168
Aust N Z J Psychiatry. 2010 May;44(5):435-42
pubmed: 20397785
Transl Psychiatry. 2017 May 30;7(5):e1139
pubmed: 28556831
J Child Adolesc Psychopharmacol. 2017 Feb;27(1):95-100
pubmed: 26771226
Health Promot Chronic Dis Prev Can. 2016 Sep;36(9):194-8
pubmed: 27670922
Dev Med Child Neurol. 2013 Nov;55(11):980-7
pubmed: 23742661
BMC Psychiatry. 2014 Dec 02;14:344
pubmed: 25439055
Can J Cardiol. 2021 Sep;37(9):1322-1331
pubmed: 33276049
Am J Epidemiol. 2006 Nov 15;164(10):947-54
pubmed: 16914506
J Psychiatr Res. 2020 Nov;130:306-312
pubmed: 32866680
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Int Rev Psychiatry. 2010;22(5):437-52
pubmed: 21047158
Psychol Trauma. 2015 May;7(3):243-51
pubmed: 25961869
Int J Obes (Lond). 2006 Apr;30(4):590-4
pubmed: 16570087
J Affect Disord. 2015 Jul 15;180:142-7
pubmed: 25909752
Psychol Bull. 2017 Aug;143(8):783-822
pubmed: 28447828
Psychol Med. 1998 Jan;28(1):51-61
pubmed: 9483683
Asian J Psychiatr. 2016 Jun;21:51-66
pubmed: 27208458
Eur J Epidemiol. 2010 Mar;25(3):163-72
pubmed: 20127393
Prev Chronic Dis. 2009 Oct;6(4):A121
pubmed: 19754997
J Affect Disord. 2019 Jun 15;253:232-239
pubmed: 31055129
Cogn Emot. 2015;29(8):1496-504
pubmed: 25517734
Arch Gen Psychiatry. 2003 Mar;60(3):253-8
pubmed: 12622658
Bipolar Disord. 2013 Nov;15(7):764-73
pubmed: 23909952
Psychiatry Res. 2010 Jul 30;178(2):230-5
pubmed: 20462641
Mol Psychiatry. 2022 Jan;27(1):281-295
pubmed: 34079068
Am J Prev Med. 2005 Nov;29(4):265-72
pubmed: 16242588
Eur J Pediatr. 2012 Dec;171(12):1737-46
pubmed: 22383072
Depress Anxiety. 2015 Sep;32(9):684-92
pubmed: 25693731
Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84
pubmed: 22865617
Bipolar Disord. 2016 Aug;18(5):440-50
pubmed: 27566286
PLoS One. 2020 May 5;15(5):e0232238
pubmed: 32369502
Can J Psychiatry. 2000 May;45(4):340-8
pubmed: 10813067
J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1427-39
pubmed: 8936909
J Am Med Inform Assoc. 2017 Nov 01;24(6):1080-1087
pubmed: 28453637

Auteurs

Nitya Adepalli (N)

Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Jill Cumby (J)

Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Niamh Campbell (N)

Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Barbara Pavlova (B)

Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Martin Alda (M)

Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Leah E Cahill (LE)

Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Rudolf Uher (R)

Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH